Immediate Impact
1 from Science/Nature 53 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Valerio D’Alicandro being referenced
PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Valerio D’Alicandro | 76 | 174 | 112 | 130 | 8 | 306 | |
| Arianna Citti | 112 | 130 | 112 | 104 | 8 | 311 | |
| Nai‐Kong V. Cheung | 145 | 95 | 81 | 194 | 8 | 319 | |
| Alessandra Jales | 118 | 137 | 143 | 40 | 6 | 327 | |
| Wing C. Chan | 46 | 137 | 111 | 57 | 10 | 341 | |
| P. Dominick Sanders | 78 | 247 | 165 | 33 | 11 | 369 | |
| Laura Lorenzo-Sanz | 116 | 130 | 67 | 42 | 8 | 267 | |
| Jutta Meltzer | 104 | 261 | 178 | 66 | 11 | 364 | |
| Anne-Catherine Jallas | 193 | 184 | 51 | 65 | 8 | 322 | |
| Ahmed Bedeir | 83 | 143 | 48 | 41 | 9 | 292 | |
| Lora Zhao | 113 | 78 | 136 | 40 | 7 | 334 |
All Works
Loading papers...